Tardive Dyskinesia Impact Scale Captures Relevant Info About Condition
By Elana Gotkine HealthDay Reporter
FRIDAY, Jan. 19, 2024 -- The Tardive Dyskinesia Impact Scale (TDIS) patient-reported outcome measure captures information about the impact of TD, according to a study published online Jan. 4 in the Journal of Patient-Reported Outcomes.
Robert H. Farber, Ph.D., from Neurocrine Biosciences Inc. in San Diego, and colleagues used data from qualitative studies and phase 3 trials of a VMAT2 inhibitor for treatment of TD to determine the psychometric properties of the TDIS. To assess how well the TDIS captured key domains of TD impact, qualitative research included concept elicitation and cognitive debriefing interviews with TD patients and their caregivers. The psychometric properties of the TDIS were examined with quantitative analysis including assessing construct validity and responsiveness to change.
The researchers found that the key TD impacts reported by patients and caregivers were captured by the TDIS; the TDIS was interpreted as intended and relevant to patients' experiences based on qualitative results. Evidence of two underlying domains of the TDIS was found in quantitative results: physical and socioemotional. Compared with the clinician-rated outcome (Abnormal Involuntary Movement Scale), the TDIS captured unique content based on known groups and predictive validity. Responsiveness to change in treatment was seen with the TDIS, with improvement noted in TDIS scores over 48 weeks in two phase 3 trials.
"The TDIS can be easily administered in a clinician's office or at a patient's home to provide insight about TD impact and whether the impact is lessening or increasing," the authors write.
Several authors disclosed ties to biopharmaceutical companies, including Neurocrine Biosciences, which funded the study.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted January 2024
Read this next
High Rates of Harassment Behaviors Observed in Obstetrics and Gynecology
THURSDAY, May 9, 2024 -- There are high rates of harassment behaviors within the obstetrics and gynecology (OB-GYN) specialty, according to a review published online May 8 in JAMA...
Personalized Tool Can Predict Infants at Increased Risk for RSV
THURSDAY, May 9, 2024 -- A personalized tool can predict infants at increased risk for severe respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI) who would...
Mortality Slightly Increased With Consumption of Ultraprocessed Foods
THURSDAY, May 9, 2024 -- Mortality is slightly higher in association with a higher intake of ultraprocessed foods, according to a study published online May 8 in The BMJ. Zhe...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.